Adma Biologics | ADMA - Capital Ordinaire

Prix De L'Action
9.70
Variation Quotidienne
-0.24 -2.41%
Mensuellement
-38.10%
Annuel
-50.00%
Q2 Prévisions
9.44




Capital Ordinaire Changement Date
Adma Biologics USD 237.88M 457K 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
BioCryst Pharmaceuticals USD 213.06M 2.54M 2025-12
Minerva Neurosciences USD 1000 0 2024-09
Novavax USD 162.58M 106K 2025-12
Omeros USD 611K 17K 2023-12
Takeda JPY 1.58B 2K 2025-12